Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Withdrawn 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 34INDUSTRY 17NIH 2FED 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Gastrointestinal 1Breast 1

Conditions

Lung Neoplasms 3Urinary Bladder Neoplasms 2Colorectal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Urinary Incontinence 1Ureteral Neoplasms 1Prostatic Neoplasms 1Papillomavirus Infections 1Health Education 1Erectile Dysfunction 1Colonic Polyps 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Atypical Squamous Cells of the Cervix 1

Interventions

copanlisib 1avelumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × FED × Urinary Bladder Neoplasms × Clear all
NCT05687721 2025-06-15

Copanlisib and Avelumab as a Maintenance Therapy for Advanced Bladder Cancer

VA Office of Research and Development

Phase 1/2 Withdrawn
Genitourinary

Urinary Bladder Neoplasms, Ureteral Neoplasms

NCT01710293 2018-02-26

PACT CREATE 3

VA Office of Research and Development

Phase NA Withdrawn
BreastGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Hepatocellular, Lung Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡